|
OSBPL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.016500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.962730E-03 |
| Normal-vs-Stage2 |
2.031600E-01 |
| Normal-vs-Stage3 |
2.17249999999725E-05 |
| Normal-vs-Stage4 |
4.178000E-04 |
| Stage1-vs-Stage2 |
9.461900E-02 |
| Stage1-vs-Stage3 |
2.718200E-03 |
| Stage1-vs-Stage4 |
3.149200E-01 |
| Stage2-vs-Stage3 |
7.901500E-03 |
| Stage2-vs-Stage4 |
3.552000E-02 |
| Stage3-vs-Stage4 |
5.552400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.619120E-03 |
| Normal-vs-AfricanAmerican |
2.615900E-03 |
| Normal-vs-Asian |
6.263900E-02 |
| Caucasian-vs-AfricanAmerican |
9.761600E-01 |
| Caucasian-vs-Asian |
5.795800E-01 |
| AfricanAmerican-vs-Asian |
5.803600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.717720E-03 |
| Normal-vs-Female |
2.222200E-03 |
| Male-vs-Female |
6.397200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.302900E-03 |
| Normal-vs-Extreme_Weight |
1.299360E-03 |
| Normal-vs-Obese |
2.904000E-03 |
| Normal-vs-Extreme_Obese |
2.462000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.099400E-01 |
| Normal_Weight-vs-Obese |
7.865600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.822800E-01 |
| Extreme_Weight-vs-Obese |
6.390200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.827200E-01 |
| Obese-vs-Extreme_Obese |
4.892000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.575880E-02 |
| Normal-vs-Age(41-60Yrs) |
5.515500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.421850E-03 |
| Normal-vs-Age(81-100Yrs) |
1.629870E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.205000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.631200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.870500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.014800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.351600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.212040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.176300E-03 |
| Normal-VS-Type2 PRCC |
2.389600E-04 |
| Normal-VS-KIRP CIMP |
3.108100E-02 |
| Normal-VS-Unclassified PRCC |
4.004000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.966200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.464600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.897800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.055000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.711800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.933600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.441540E-04 |
| Normal-vs-N1 |
2.569500E-04 |
| Normal-vs-N2 |
1.477810E-01 |
| N0-vs-N1 |
9.884400E-01 |
| N0-vs-N2 |
8.660000E-01 |
| N1-vs-N2 |
8.596400E-01 |
|
|
